Expert clarifies limited evidence linking GLP-1 agonists to improved male fertility

Medical experts are tempering expectations regarding the use of GLP-1 receptor agonists like semaglutide and tirzepatide as direct treatments for male infertility. While weight loss associated with these drugs may indirectly benefit reproductive health, clinical evidence confirming a direct pharmacological improvement in fertility remains insufficient.